vs

Side-by-side financial comparison of ONESPAWORLD HOLDINGS Ltd (OSW) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.

ONESPAWORLD HOLDINGS Ltd is the larger business by last-quarter revenue ($242.1M vs $164.7M, roughly 1.5× PTC THERAPEUTICS, INC.). ONESPAWORLD HOLDINGS Ltd runs the higher net margin — 5.0% vs -82.0%, a 86.9% gap on every dollar of revenue. On growth, ONESPAWORLD HOLDINGS Ltd posted the faster year-over-year revenue change (11.5% vs -22.7%). ONESPAWORLD HOLDINGS Ltd produced more free cash flow last quarter ($14.9M vs $-36.6M). Over the past eight quarters, ONESPAWORLD HOLDINGS Ltd's revenue compounded faster (7.1% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

OSW vs PTCT — Head-to-Head

Bigger by revenue
OSW
OSW
1.5× larger
OSW
$242.1M
$164.7M
PTCT
Growing faster (revenue YoY)
OSW
OSW
+34.2% gap
OSW
11.5%
-22.7%
PTCT
Higher net margin
OSW
OSW
86.9% more per $
OSW
5.0%
-82.0%
PTCT
More free cash flow
OSW
OSW
$51.6M more FCF
OSW
$14.9M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
OSW
OSW
Annualised
OSW
7.1%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OSW
OSW
PTCT
PTCT
Revenue
$242.1M
$164.7M
Net Profit
$12.1M
$-135.0M
Gross Margin
Operating Margin
6.8%
-43.3%
Net Margin
5.0%
-82.0%
Revenue YoY
11.5%
-22.7%
Net Profit YoY
-16.2%
-104.8%
EPS (diluted)
$0.12
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OSW
OSW
PTCT
PTCT
Q4 25
$242.1M
$164.7M
Q3 25
$258.5M
$211.0M
Q2 25
$240.7M
$178.9M
Q1 25
$219.6M
$1.2B
Q4 24
$217.2M
$213.2M
Q3 24
$241.7M
$196.8M
Q2 24
$224.9M
$186.7M
Q1 24
$211.2M
$210.1M
Net Profit
OSW
OSW
PTCT
PTCT
Q4 25
$12.1M
$-135.0M
Q3 25
$24.3M
$15.9M
Q2 25
$19.9M
$-64.8M
Q1 25
$15.3M
$866.6M
Q4 24
$14.4M
$-65.9M
Q3 24
$21.6M
$-106.7M
Q2 24
$15.8M
$-99.2M
Q1 24
$21.2M
$-91.6M
Operating Margin
OSW
OSW
PTCT
PTCT
Q4 25
6.8%
-43.3%
Q3 25
10.2%
1.4%
Q2 25
9.2%
-19.5%
Q1 25
7.7%
82.5%
Q4 24
7.9%
-76.2%
Q3 24
10.3%
-27.7%
Q2 24
8.4%
-21.5%
Q1 24
8.0%
-21.6%
Net Margin
OSW
OSW
PTCT
PTCT
Q4 25
5.0%
-82.0%
Q3 25
9.4%
7.5%
Q2 25
8.3%
-36.3%
Q1 25
7.0%
73.7%
Q4 24
6.6%
-30.9%
Q3 24
8.9%
-54.2%
Q2 24
7.0%
-53.1%
Q1 24
10.0%
-43.6%
EPS (diluted)
OSW
OSW
PTCT
PTCT
Q4 25
$0.12
$-1.63
Q3 25
$0.23
$0.20
Q2 25
$0.19
$-0.83
Q1 25
$0.15
$10.04
Q4 24
$0.13
$-0.85
Q3 24
$0.20
$-1.39
Q2 24
$0.15
$-1.29
Q1 24
$0.21
$-1.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OSW
OSW
PTCT
PTCT
Cash + ST InvestmentsLiquidity on hand
$16.3M
$1.9B
Total DebtLower is stronger
$84.0M
Stockholders' EquityBook value
$542.6M
$-205.3M
Total Assets
$707.1M
$2.9B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OSW
OSW
PTCT
PTCT
Q4 25
$16.3M
$1.9B
Q3 25
$29.6M
$1.7B
Q2 25
$35.0M
$2.0B
Q1 25
$22.6M
$2.0B
Q4 24
$57.4M
$1.1B
Q3 24
$48.8M
$1.0B
Q2 24
$62.5M
$1.1B
Q1 24
$65.4M
$884.8M
Total Debt
OSW
OSW
PTCT
PTCT
Q4 25
$84.0M
Q3 25
$85.2M
Q2 25
$96.2M
Q1 25
$97.4M
Q4 24
$98.6M
Q3 24
$98.7M
Q2 24
$123.8M
Q1 24
$138.6M
Stockholders' Equity
OSW
OSW
PTCT
PTCT
Q4 25
$542.6M
$-205.3M
Q3 25
$552.8M
$-155.8M
Q2 25
$548.3M
$-206.5M
Q1 25
$530.6M
$-185.8M
Q4 24
$554.5M
$-1.1B
Q3 24
$540.1M
$-1.1B
Q2 24
$532.7M
$-980.2M
Q1 24
$515.5M
$-893.9M
Total Assets
OSW
OSW
PTCT
PTCT
Q4 25
$707.1M
$2.9B
Q3 25
$732.6M
$2.6B
Q2 25
$731.8M
$2.6B
Q1 25
$708.7M
$2.7B
Q4 24
$746.4M
$1.7B
Q3 24
$734.0M
$1.8B
Q2 24
$756.8M
$1.9B
Q1 24
$763.6M
$1.8B
Debt / Equity
OSW
OSW
PTCT
PTCT
Q4 25
0.15×
Q3 25
0.15×
Q2 25
0.18×
Q1 25
0.18×
Q4 24
0.18×
Q3 24
0.18×
Q2 24
0.23×
Q1 24
0.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OSW
OSW
PTCT
PTCT
Operating Cash FlowLast quarter
$20.0M
$-34.3M
Free Cash FlowOCF − Capex
$14.9M
$-36.6M
FCF MarginFCF / Revenue
6.2%
-22.3%
Capex IntensityCapex / Revenue
2.1%
1.4%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$68.4M
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OSW
OSW
PTCT
PTCT
Q4 25
$20.0M
$-34.3M
Q3 25
$33.2M
$-66.3M
Q2 25
$20.3M
$-58.3M
Q1 25
$10.1M
$870.1M
Q4 24
$16.6M
$-30.0M
Q3 24
$28.6M
$-77.0M
Q2 24
$18.7M
$-71.5M
Q1 24
$15.0M
$70.8M
Free Cash Flow
OSW
OSW
PTCT
PTCT
Q4 25
$14.9M
$-36.6M
Q3 25
$27.6M
$-69.7M
Q2 25
$17.6M
$-59.6M
Q1 25
$8.4M
$868.4M
Q4 24
$13.2M
$-33.8M
Q3 24
$27.5M
$-77.5M
Q2 24
$17.6M
$-78.8M
Q1 24
$13.7M
$61.2M
FCF Margin
OSW
OSW
PTCT
PTCT
Q4 25
6.2%
-22.3%
Q3 25
10.7%
-33.1%
Q2 25
7.3%
-33.3%
Q1 25
3.8%
73.8%
Q4 24
6.1%
-15.8%
Q3 24
11.4%
-39.4%
Q2 24
7.8%
-42.2%
Q1 24
6.5%
29.1%
Capex Intensity
OSW
OSW
PTCT
PTCT
Q4 25
2.1%
1.4%
Q3 25
2.2%
1.6%
Q2 25
1.1%
0.7%
Q1 25
0.8%
0.1%
Q4 24
1.5%
1.8%
Q3 24
0.5%
0.3%
Q2 24
0.5%
4.0%
Q1 24
0.6%
4.6%
Cash Conversion
OSW
OSW
PTCT
PTCT
Q4 25
1.65×
Q3 25
1.36×
-4.17×
Q2 25
1.02×
Q1 25
0.66×
1.00×
Q4 24
1.15×
Q3 24
1.33×
Q2 24
1.19×
Q1 24
0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OSW
OSW

Services$197.3M82%
Products$44.8M18%

PTCT
PTCT

Segment breakdown not available.

Related Comparisons